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Abstract
Aim: The present study was aimed at polymerase chain reaction (PCR) amplification and cloning of NAD-dependent beta-
hydroxybutyryl coenzyme A dehydrogenase (BHBD) gene of Clostridium chauvoei.
Materials and Methods: C. chauvoei was cultured and confirmed by 16-23S rDNA spacer region primers. The primers for 
nad-bhbd gene of C. chauvoei were designed to aid in cloning into pRham-N-His SUMO-Kan vector, and nad-bhbd gene 
was amplified by PCR. The amplified nad-bhbd gene was purified and cloned into pRham-N-His SUMO-Kan expression 
vector. The recombinant plasmid was transformed into E. cloni 10 G cells and the clone was confirmed by colony PCR using 
the pRham-SUMO-NAD-For and pRham-SUMO-NAD-Rev primers and also by sequencing.
Results: PCR amplification of nad-bhbd gene yielded a product length of 844 base pairs which was cloned into pRham-N-
His SUMO-Kan vector followed by transformation into E. cloni 10G chemically competent cells. The recombinant clones 
were characterized by colony PCR, sequencing, followed by basic local alignment search tool (BLAST) analysis to confirm 
the insert.
Conclusions: Immunogenic protein NAD- dependent BHBD of C. chauvoei was cloned and the recombinant clones were 
confirmed by colony PCR and sequencing analysis.
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Introduction
Black quarter is one of the important bacterial dis-
eases of domestic animals, which affect mainly cattle, 
buffaloes, and sheep. It is caused by Clostridium chau-
voei, a Gram-positive, motile, spore-forming bacilli. It 
is the second most important bacterial disease in India 
next only to hemorrhagic septicemia in causing death 
among bovids. C. chauvoei is one of the most patho-
genic Clostridium species causing considerable losses 
in livestock production [1]. According to the report 
by Department of Animal husbandry, Fisheries and 
Dairying, Government of India, there were about 417 
outbreaks across the country in which 2676 cattle and 
buffaloes were affected and 900 animals died in the 
year 2011 alone [2]. Although C. chauvoei is gener-
ally considered to be specific for ruminants, there are 
reports of black quarter in nonruminants such as pig, 
mink, fresh water fish, whales, frogs, elephant, and 
humans [3-8]. Ruminants are exposed to the patho-
gen by ingestion of C. chauvoei spores present in the 
soil, which then induce cell necrosis, edemic lesions 
and fever followed by lameness and death [9-11]. 
Treatment is of limited value, considering the acute 
nature of the disease, and the vaccination remains 
the preferred control measure in the field conditions. 
Whole inactivated bacteria and chemically toxoided 
culture supernatants were most commonly used for 
the prophylaxis of blackleg [12]. C. chauvoei flagella 
plays an important role in virulence and are the only 
particular antigens for which there is any evidence of 
involvement in inducing protective immunity against 
blackleg [13-15]. Besides, C. chauvoei also produces 
four toxins viz., oxygen-stable hemolysin, oxygen-la-
bile hemolysin, DNase and hyaluronidase, and also 
a neuraminidase [16-19]. A 27 kDa hemolysin was 
purified from C. chauvoei strain C6H but was not 
further characterized [18]. Recently, another toxin 
gene, C. chauvoei toxin A (cctA), which is both cyto-
lytic and hemolytic, has been cloned, sequenced, and 
expressed [20].
In a quest for the protective antigens of 
C. chauvoei, using 2D-gel electrophoresis and mass 
spectrometry approaches, several immunogenic 
proteins were identified in our laboratory (unpub-
lished data). Among these, one important immu-
nogenic protein identified was NAD-dependent 
beta-hydroxybutyryl-coenzyme A dehydrogenase 
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(NAD-BHBD). The 3-hydroxybutyryl-CoA dehy-
drogenase was identified as immunogenic protein 
molecule of Flavobacterium columnare, which 
causes columnaris disease in fish, and it may be a 
candidate molecule for the development of vaccines 
against columnaris disease [21].
Currently, the information available regarding 
the NAD-BHBD is very scanty. As a first step in the 
characterization of immunogenic potential of this pro-
tein, in the present study, we identified and amplified 
the nad-bhbd gene, and cloned in prokaryotic expres-
sion vector.
Materials and Methods
Ethical approval
There was no use of live animal in the study.
Bacteria
The bacteria C. chauvoei American type culture 
collection (ATCC 10092) used in the present study 
was obtained and procured from LGC promochem 
pvt. Ltd., Bangalore.
Genomic DNA isolation
The bacterials strain were cultured in ATCC 
2107 media (1% tryptose, 1% beef extract, 0.3% 
yeast extract, 0.5% dextrose, 0.5% NaCl, 0.1% sol-
uble starch, 0.05% L-cystine HCl, and 0.03% Na 
acetate) at 37°C for 48 h and the genomic DNA was 
extracted by CTAB-NaCl method [22]. About 3-5 ml 
of late logarithmic bacterial culture was centrifuged 
at 9,300 g for 10 min to separate bacterial cells from 
supernatant. The bacterial pellet was washed twice 
with phosphate buffered saline. The pellet was again 
suspended in lysis buffer (200 μl of × 1 TE, 300 μl of 
10% sodium dodecyl sulfate and 5 μl of proteinase K) 
and incubated at 37°C for 1 h. Resuspension of the 
cells in lysate solution (500 μl of 5 M NaCl and 100 μl 
CTAB) was done, and samples were kept in the water 
bath at 63°C for 10 min. Equal volume of chloroform: 
Isoamyl alcohol (24:1) was added, and centrifugation 
at 15,700 g for 10 min was done. To the supernatant, 
1/10th volume of 7.5 M ammonium acetate and 2 vol-
ume of chilled ethanol was added followed by centrif-
ugation at 9,300 g for 20 min at 4°C. Resuspension 
of the pellet in elution buffer was done followed by 
storage at −20°C.
Confirmation of C. chauvoei by 16-23S rDNA spacer 
region primers
Polymerase chain reaction (PCR) amplifica-
tion of 16-23S rDNA was performed as described by 
Sasaki et al. [23]. The identification of C. chauvoei 
was carried out using the specific primers (IGSCS and 
23 UPCH primers) targeting 16S-23S rDNA spacer 
region.
PCR amplification of nad-bhbd gene of C. chauvoei
The primers were designed from available 
sequence of nad-bhbd gene of C. chauvoei in NCBI 
(accession number-CMBL 010000001.1), to aid in 
cloning into pRham-N-His small ubiquitin-related 
modifier (SUMO)-Kan vector and the sequence of the 
primers designed is given below.
pRham-SUMO-NAD-For-CGCGAA-
CAGATTGGAGGTGAAAAGATTTTTGTA-
ATTGGT
pRham-SUMO-NAD-Rev-GTGGCGGC-
CGCTCTATTATCTGCTATAGTCGTAGAATCC
PCR was carried out in the volume of 25 μl 
reaction mixture containing 10 ng of genomic DNA, 
2.5 μl of × 10 thermopol buffer, 3 μl MgSO4 (25 mM), 
0.5 μl dNTPs (10 mM), 10 pmol each of the primer 
and vent polymerase. PCR was performed in ther-
mocycler (Eppendorf, Mastercycler) using a program 
consisting initial denaturation temperature of 94°C for 
5 min followed by 40 cycles of denaturation of 94°C 
for 1 min, annealing temperature of 59°C for 1 min 
and extension of 72°C for 1 min 30 s. Final extension 
was carried out at 72°C for 10 min.
Cloning of nad-bhbd gene and confirmation of the 
recombinant clones
The amplified nad-bhbd gene was purified by 
qiagen gel extraction kit (Qiagen, Germany) and 
cloned into pRham-N-His SUMO-Kan expression 
vector (Lucigen Corporation, Wisconsin, USA) 
using manufacturer’s protocol. The recombinant 
plasmid was transformed into E. cloni 10 G cells and 
the clone was confirmed by colony PCR using the 
pRham-SUMO-NAD-For and pRham-SUMO-NAD-
Rev primers (Lucigen Corporation, Wisconsin, USA) 
and also by sequencing. pRham-N-His SUMO-Kan-
nad-bhbd construct was sequenced at a custom DNA 
Sequencing facility (Eurofins). Sequences were 
analyzed using DNASTAR Lasergene software 
(DNASTAR, Inc., USA) and subjected to analysis 
using basic local alignment search tool (BLAST) pro-
gram of NCBI (National Centre for Biotechnology 
Information) against the draft genome sequence 
of  C. chauvoei. Nucleotide sequence of nad-bhbd 
gene was submitted to NCBI nucleotide sequence 
database and has been assigned accession number, 
KM051572.
Results
Confirmation of C. chauvoei by PCR
PCR confirmation of culture was done using 
primers specific for 16S-23S rDNA spacer region [23] 
using C. chauvoei enomic DNA as template. Agarose 
gel electrophoresis analysis of the PCR product 
showed specific amplification product length of 522 bp 
(Figure-1) confirming the identity of C. chauvoei.
PCR amplification of nad-bhbd gene of C. chauvoei
nad-bhbd gene of C. chauvoei was amplified by 
self-designed gene-specific primers using C. chauvoei 
DNA as template. Amplified product was analyzed by 
1.5% agarose gel electrophoresis which showed an 
intense amplification at 844 bp (Figure-2) as expected. 
The PCR amplified nad-bhbd gene was eluted using 
gel extraction kit. The yield of the eluted DNA was 
approximately 80% of the original PCR product, and Available at www.veterinaryworld.org/Vol.7/October-2014/18.pdf
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the DNA was obtained as a distinct band without any 
smearing.
Cloning of nad-bhbd gene of C. chauvoei
The PCR products having the SUMO flanking 
region were ligated with pRham N-His SUMO vector 
and transformed into E. cloni 10 G cells and plated on 
LB kanamycin agar, and incubated overnight at 37°C. 
LB kanamycin agar plate showed only two colonies. 
Both the colonies were inoculated into 5 ml LB broth 
containing kanamycin. LB broth containing single 
colony kept for overnight growth in a shaker incuba-
tor at 37°C and 180 rpm. pRham N-His-SUMO-nad-
bhbd clones were then confirmed by colony PCR, 
which showed amplicons of 844 bp size as expected 
(Figure-3). Plasmid was isolated from these clones 
and sent for sequencing using sequencing primers 
specific for the vector backbone. Sequence analysis 
confirmed that the clones were indeed positive for 
nad-bhbd gene (Figure-4). Sequence was then ana-
lyzed against the nucleotide sequence database using 
BLAST program of NCBI. Based on the maximum 
identity score, insert sequence had 100% identity at 
nucleotide level with nad-bhbd gene of C. chauvoei 
strain JF4335, confirming that the gene cloned in the 
pRham N-His SUMO vector was indeed the nad-bhbd 
gene.
Discussion
Black quarter, caused by a Gram-positive, anaer-
obic spore-forming rod called C. chauvoei, is a dread-
ful disease affecting ruminant population. Several 
virulence factors have been proposed to be produced 
by C. chauvoei, including alpha, beta, gamma, and 
delta toxins, and neuraminidase [11]. However, most 
of this information is based on the studies conducted 
in a very closely related species, C. septicum. Very few 
studies have been conducted in C. chauvoei to estab-
lish the actual role of these proposed virulence factors. 
Recently, another toxin gene, cctA, which is both cyto-
lytic and hemolytic, has been cloned, sequenced and 
expressed [20]. They showed that cctA protein had 
hemolytic and cytotoxic activity, and offered protec-
tion against virulent spores of C. chauvoei. However, 
the protective antigens of C. chauvoei are not yet fully 
characterized.
In a recent work in our laboratory, using the 2D-gel 
electrophoresis and mass spectrometry approaches, 
several immunogenic cell-surface associated proteins 
Figure-1: DNA electrophoresis of polymerase chain 
reaction (PCR) amplicons of 16S-23S rDNA spacer gene. 
M-DNA ladder, 1-PCR product, 2-Negative control.
Figure-2: Electrophoresis of amplificated DNA of nad-bhbd 
gene of Clostridium chauvoei; M-DNA ladder, 1 and 2-nad-
bhbd gene, 3-Negative control.
Figure-3: DNA electrophoresis of polymerase chain 
reaction amplicons of recombinant clones; M-DNA Ladder, 
1 and 3-nad-bhbd negative clones, 2 and 4-nad-bhbd 
positive clones.
Figure-4: Nucleotide sequence of nad-bhbd gene.Available at www.veterinaryworld.org/Vol.7/October-2014/18.pdf
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of  C. chauvoei were identified (unpublished data), 
among which NAD-BHBD, was one important 
immunogenic protein. Recently in other study, the 
3-hydroxybutyryl-CoA dehydrogenase was identified 
as immunogenic protein molecule of F. columnare, 
which causes columnaris disease in fish, and it may 
provide candidate molecules for the development of 
vaccines against columnaris disease [21]. Hence, we 
choose to characterize this gene. Accordingly, nad-
bhbd gene of C. chauvoei was amplified, cloned, and 
characterized by sequencing analysis.
Conclusion
In summary, in the present study, nad-bhbd gene 
was identified, amplified, and cloned in pRham N-His 
SUMO expression vector. The recombinant clone was 
confirmed by colony PCR using gene-specific prim-
ers and by sequencing of the insert. However, further 
research is required to express the nad-bhbd gene in 
E. cloni and to evaluate if the recombinant NAD-
BHBD protein has immunogenic potential.
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